Stroke

• FDA label_change · 2023-06-07
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)

  FDA supplemental application for Losartan Potassium by Macleods Pharmaceuticals Limited, likely involving labeling changes for the generic d…

• FDA label_change · 2020-08-20
  FDA Approved: HYZAAR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) filed by Organon LLC, resulting in changes t…